2021
Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis
Wong BM, Perry JJ, Cheng W, Zheng B, Guo K, Taljaard M, Skanes AC, Stiell IG. Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis. Canadian Journal Of Emergency Medicine 2021, 23: 500-511. PMID: 33715143, DOI: 10.1007/s43678-021-00103-0.Peer-Reviewed Original ResearchConceptsOral anticoagulation useAcute atrial fibrillationAnticoagulation useThromboembolic eventsAtrial fibrillationThromboembolic riskFlutter patientsInsufficient evidencePrimary analysisSecondary analysisDerSimonian-Laird random-effects modelSafety of cardioversionPrognostic Studies toolRisk of biasRandom-effects modelBackgroundRecent studiesInclusion criteriaMAIN OUTCOMELower riskFibrillationSystematic reviewEvent ratesCardioversionMore studiesPatients
2018
The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis
Montroy J, Hutton B, Moodley P, Fergusson NA, Cheng W, Tinmouth A, Lavallée LT, Fergusson DA, Breau RH. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfusion Medicine Reviews 2018, 32: 165-178. PMID: 29567052, DOI: 10.1016/j.tmrv.2018.02.003.Peer-Reviewed Original ResearchTopical tranexamic acidTranexamic acidBlood lossIntravenous administrationTransfusion requirementsTopical applicationIntravenous tranexamic acidNon-surgical trialsVenous thromboembolic complicationsMean blood lossCochrane Central RegisterFull-text selectionMajority of trialsEffective hemostatic agentIntravenous groupThromboembolic riskVenous thromboembolismAdult patientsCentral RegisterThromboembolic complicationsBlood transfusionControlled TrialsTransfusion riskSafety profileSystemic absorption